中华行为医学与脑科学杂志
中華行為醫學與腦科學雜誌
중화행위의학여뇌과학잡지
CHINESE JOURNAL OF BEHAVIORAL MEDICINE AND BRAIN SCIENCE
2009年
2期
103-104
,共2页
唐亚梅%陈体%张晓洁%罗昔波%刘勇
唐亞梅%陳體%張曉潔%囉昔波%劉勇
당아매%진체%장효길%라석파%류용
精神分裂症%犬尿氨酸%犬尿喹啉酸%高效液相色谱法
精神分裂癥%犬尿氨痠%犬尿喹啉痠%高效液相色譜法
정신분렬증%견뇨안산%견뇨규람산%고효액상색보법
Schizophrenia%Kynurenine%Kynurenic acid%High performance liquid chromatography
目的 研究精神分裂症(SZ)患者血清犬尿氨酸(KYN)和犬尿喹啉酸(KYNA)的浓度变化以及不同临床分型患者之间二者浓度的差异性.方法 采用高效液相色谱-荧光检测法(HPLC-FLD)检测SZ患者和正常对照人群以及不同临床分型患者血清KYN和KYNA含量并计算KYN/KYNA比值.结果 SZ患者血清KYN水平[(2.148±0.605)μmol/L]与正常对照组[(2.108±0.592)μmol/L]比较差异无显著性意义( t =0.675,P >0.05),血清KYNA水平[(24.231±6.831)nmol/L]低于正常对照组[(29.420±7.595)nmol/L]( t =1.657,P <0.05), KYN/KYNA比值(111.496±23.797)高于正常对照组(80.330±17.639)( t =1.654,P <0.05).偏执型SZ患者血清KYN含量低于青春型,血清KYNA含量高于单纯型和青春型;青春型KYN/KYNA比值高于偏执型和未分型,均差异有显著性( P <0.05).结论 SZ患者血清KYNA水平和KYN/KYNA比值可为SZ的临床诊断和治疗提供实验室依据.
目的 研究精神分裂癥(SZ)患者血清犬尿氨痠(KYN)和犬尿喹啉痠(KYNA)的濃度變化以及不同臨床分型患者之間二者濃度的差異性.方法 採用高效液相色譜-熒光檢測法(HPLC-FLD)檢測SZ患者和正常對照人群以及不同臨床分型患者血清KYN和KYNA含量併計算KYN/KYNA比值.結果 SZ患者血清KYN水平[(2.148±0.605)μmol/L]與正常對照組[(2.108±0.592)μmol/L]比較差異無顯著性意義( t =0.675,P >0.05),血清KYNA水平[(24.231±6.831)nmol/L]低于正常對照組[(29.420±7.595)nmol/L]( t =1.657,P <0.05), KYN/KYNA比值(111.496±23.797)高于正常對照組(80.330±17.639)( t =1.654,P <0.05).偏執型SZ患者血清KYN含量低于青春型,血清KYNA含量高于單純型和青春型;青春型KYN/KYNA比值高于偏執型和未分型,均差異有顯著性( P <0.05).結論 SZ患者血清KYNA水平和KYN/KYNA比值可為SZ的臨床診斷和治療提供實驗室依據.
목적 연구정신분렬증(SZ)환자혈청견뇨안산(KYN)화견뇨규람산(KYNA)적농도변화이급불동림상분형환자지간이자농도적차이성.방법 채용고효액상색보-형광검측법(HPLC-FLD)검측SZ환자화정상대조인군이급불동림상분형환자혈청KYN화KYNA함량병계산KYN/KYNA비치.결과 SZ환자혈청KYN수평[(2.148±0.605)μmol/L]여정상대조조[(2.108±0.592)μmol/L]비교차이무현저성의의( t =0.675,P >0.05),혈청KYNA수평[(24.231±6.831)nmol/L]저우정상대조조[(29.420±7.595)nmol/L]( t =1.657,P <0.05), KYN/KYNA비치(111.496±23.797)고우정상대조조(80.330±17.639)( t =1.654,P <0.05).편집형SZ환자혈청KYN함량저우청춘형,혈청KYNA함량고우단순형화청춘형;청춘형KYN/KYNA비치고우편집형화미분형,균차이유현저성( P <0.05).결론 SZ환자혈청KYNA수평화KYN/KYNA비치가위SZ적림상진단화치료제공실험실의거.
Objective To investigate the clinical significance of serum kynurenine (KYN) and kynurenic acid (KYNA) determined in patients with schizophrenia(SZ)by observing the differences of serum KYN and KYNA between schizophrenia and healthy controls.Methods The serum KYN and KYNA level in schizophrenia and healthy controls were measured by high performance liquid chromatography-fluorescence (HPLC-FLD) and the content ratio of KYN to KYNA were calculated.Results The serum KYN levels had not significantly difference between schizophrenia[(2.148±0.605)μmol/L] and controls[(2.108±0.592)μmol/L]( t =0.675,P >0.05).In schizophrenia the serum KYNA [(24.231±6.831)nmol/L] was significantly decreased compare with controls [(29.420±7.595)nmol/L]( t =1.657,P <0.05), while the content ratio of KYN to KYNA (111.496±23.797) was higher than the controls(80.330±17.639) ( t =1.654,P <0.05).In paranoid schizophrenia the serum KYN was lower than it in hebephrenic schizophrenia. In paranoid schizophrenia the serum KYNA was higher than it in simple and hebephrenic schizophrenia.In hebephrenic schizophrenia the content ratio of KYN to KYNA was higher than it in paranoid and undifferentiated schizophrenia.Conclusion The serum KYNA levels and KYN/KYNA ratio in schizophrenia can be used for clinic diagnosis and therapy of schizophrenia.